AMBORA s.r.o.

At AMBORA s.r.o. in Martin, clinical research in cardiovascular diseases focuses on atherosclerotic cardiovascular disease and related risk reduction. The trials are designed to evaluate whether new therapies can lower the chance of serious heart and blood vessel events and improve overall cardiovascular outcomes.

• Research on elevated lipoprotein(a) as a cardiovascular risk factor
• Studies targeting prevention of major adverse cardiovascular events
• Evaluation of treatments intended to reduce heart-related complications

This work reflects a strong interest in improving treatment options for people at higher risk of heart attack, stroke, and other major cardiovascular events.

Clinical trials in nutritional and metabolic diseases at this hospital/clinic are centered on obesity and overweight, with attention to how these conditions affect long-term health. The research aims to assess whether new treatments can support weight-related care while also improving broader health outcomes.

• Studies in adults living with obesity
• Research involving overweight and metabolic risk
• Assessment of therapies that may help protect kidney function and reduce cardiovascular risk

These trials combine metabolic and cardiovascular interests, showing how treatment research can address both weight-related disease and complications affecting the heart and kidneys.